AAIC 2025 Abstract

Equity in diagnosis through adequate clinical trial design in diagnostic performance studies

Trial in peopleBiomarkers

Abstract

Background: Access to healthcare is unbalanced across different populations with disparities in the availability of diagnostic tests. Additionally, test development currently relies on studies with limited representation of minorities and comorbidities present in the real clinical population.

The paper

Roche Diagnostics; Roche Diagnostics International AG (Switzerland)

AAIC 2025 Abstract, 24 Dec 2025, CC BY

Presented at AAIC 2025

doi.org/10.1002/alz70856_102804